Renasant Bio
Biotechnology Research • 
Berkeley, California, United States • 21-50 Employees
Company overview
| Headquarters | Berkeley, California, United States |
| Website | |
| NAICS | 541714 |
| Employees | 21-50 |
| Socials |
Key Contacts at Renasant Bio
Anna French
Board Director
Emily Conley
Ceo
Madeleine Jensen
Associate Director, Project Management
Renasant Bio Email Formats
Renasant Bio uses 1 email format. The most common is {first name} (e.g., john@renasantbio.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@renasantbio.com | 100% |
About Renasant Bio
Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments for autosomal dominant polycystic kidney disease (ADPKD), the leading genetic cause of end-stage renal failure. Renasant is advancing a pipeline of oral small molecule corrector and potentiator programs that target the underlying biology of ADPKD to restore the function of key proteins to halt disease progression.
Renasant Bio revenue & valuation
| Annual revenue | $2,224,430 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $7,200,000 |
| Total funding | $54,500,000 |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Renasant Bio has 12 employees across 6 departments.
Departments
Number of employees
France
Singapore
Australia
Italy
Frequently asked questions
4.8
40,000 users
